Strengthening healthcare worker protection: Free Hepatitis B vaccination and screening for medical professionals in Kalisat
In a proactive measure to safeguard healthcare workers and accelerate Hepatitis B elimination by 2030, the government has announced free Hepatitis B vaccination for Named and Nakes (medical workers) in Rumah Sakit Daerah (RSD) Kalisat. The initiative aligns with the Ministry of Health’s commitment to ensure the health and safety of healthcare professionals, who are at a high risk of Hepatitis B infection and transmission.
High Prevalence and Growing Concern
Data from the Ministry of Health reveals that the prevalence of Hepatitis B among Indonesian healthcare workers currently stands at 4.7%. Meanwhile, 36.7% of Named (medical officers) and Nakes (healthcare personnel) peers have anti-HBs+ antibodies, indicating past exposure to the Hepatitis B virus or vaccination. These figures underscore the importance of heightened vigilance and prevention strategies against Hepatitis B.
Free Hepatitis B Vaccination and Screening
The upcoming Hepatitis B vaccination drive for medical professionals in RSD Kalisat will take place in two phases. First, a mandatory screening process using rapid HBsAg and anti-HBs tests will be conducted over two days, from Monday to Tuesday, December 23-24, 2024, at the RSD’s Aula building. This preliminary measure aims to detect Hepatitis B early, enabling timely intervention and prevention of severe complications.
Only those with negative or non-reactive test results for both HBsAg (indicating no Hepatitis B infection) and anti-HBs (implying no past Hepatitis B exposure or vaccination) will proceed to receive the Hepatitis B vaccine in the subsequent meeting.
The vaccination program is targeted at various healthcare professionals, including general practitioners, dental professionals, specialists in internal medicine, obstetrics & gynecology, surgery, anesthesia, clinical pathology, nurses, midwives, and medical laboratory technologists.
A Collective Effort for a Healthier Future
By organizing this free Hepatitis B vaccination and screening event, RSD Kalisat demonstrates its dedication to protecting and empowering its healthcare workforce. This concerted effort contributes significantly to the national objective of eliminating Hepatitis B by 2030, ensuring a safer and healthier future for healthcare workers and the communities they serve.
Keep reading
- New Study Reveals Dementia Rates Among Indigenous Bolivians
- Air Pollution Linked to Increased Nighttime Coughing
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)